(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






4 Result: Accenture

Eyes on the Numbers: Accenture, FedEx, and FactSet's Earnings Preview

December 16th, 2023

On Tuesday, December 19, several prominent companies are scheduled to unveil their financial performance, including: Accenture plc (NYSE: ACN), a global professional services firm, is set to release its first-quarter fiscal 2024 financial results . Read more

Setback for BrainStorm Cell Therapeutics; Accenture Posts Mixed Results

September 28th, 2023

BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI), a biotechnology company that specializes in developing innovative stem cell therapies for neurodegenerative diseases, faced a setback as the U.S. Food and Drug Administration's Cellular, Tissue, and G. Read more

Earnings Spotlight: Accenture, NIKE, and Jabil on the Horizon

September 24th, 2023

On Thursday, September 28, a number of companies are scheduled to announce their financial results, including: Accenture plc (NYSE: ACN), a global consulting and professional services firm, is set to announce its fourth-quarter and full-year fisca. Read more

Evaxion Biotech: Promising EVX-01 Clinical Data; Celsius, Accenture, Five Below: PT Raised

June 04th, 2023

Evaxion Biotech A/S (Nasdaq: EVAX) announced encouraging findings from its EVX-01 Phase 1 clinical trial, which assessed the safety and effectiveness of EVX-01 in combination with a checkpoint inhibitor for metastatic melanoma patients.  Acco. Read more

Load More Content